These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32716735)

  • 21. [Progress in somatic gene therapy of retinal degeneration in the animal model].
    Schlichtenbrede FC; Sarra GM; Ali RR; Wiedemann P; Reichel MB
    Ophthalmologe; 2002 Apr; 99(4):259-65. PubMed ID: 12058500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What Is Next for Retinal Gene Therapy?
    Vandenberghe LH
    Cold Spring Harb Perspect Med; 2015 Apr; 5(10):. PubMed ID: 25877395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina.
    Chaffiol A; Caplette R; Jaillard C; Brazhnikova E; Desrosiers M; Dubus E; Duhamel L; Macé E; Marre O; Benoit P; Hantraye P; Bemelmans AP; Bamberg E; Duebel J; Sahel JA; Picaud S; Dalkara D
    Mol Ther; 2017 Nov; 25(11):2546-2560. PubMed ID: 28807567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adeno-associated virus-vectored gene therapy for retinal disease.
    Dinculescu A; Glushakova L; Min SH; Hauswirth WW
    Hum Gene Ther; 2005 Jun; 16(6):649-63. PubMed ID: 15960597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina.
    Sarra GM; Stephens C; de Alwis M; Bainbridge JW; Smith AJ; Thrasher AJ; Ali RR
    Hum Mol Genet; 2001 Oct; 10(21):2353-61. PubMed ID: 11689482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Therapies for Inherited Retinal Diseases-Current Standing, Opportunities and Challenges.
    Vázquez-Domínguez I; Garanto A; Collin RWJ
    Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31466352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene Therapy for Retinal Degeneration.
    Apte RS
    Cell; 2018 Mar; 173(1):5. PubMed ID: 29570997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On Retinal Gene Therapy.
    Fischer MD
    Ophthalmologica; 2016; 236(1):1-7. PubMed ID: 27119148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repair of Retinal Degeneration following Ex Vivo Minicircle DNA Gene Therapy and Transplantation of Corrected Photoreceptor Progenitors.
    Barnea-Cramer AO; Singh M; Fischer D; De Silva S; McClements ME; Barnard AR; MacLaren RE
    Mol Ther; 2020 Mar; 28(3):830-844. PubMed ID: 32027843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for retinal degeneration.
    Reichel MB; Ali RR; Hunt DM; Bhattacharya SS
    Ophthalmic Res; 1997; 29(5):261-8. PubMed ID: 9323717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy beyond luxturna: a new horizon of the treatment for inherited retinal disease.
    Prado DA; Acosta-Acero M; Maldonado RS
    Curr Opin Ophthalmol; 2020 May; 31(3):147-154. PubMed ID: 32175942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina.
    Ramachandran PS; Lee V; Wei Z; Song JY; Casal G; Cronin T; Willett K; Huckfeldt R; Morgan JI; Aleman TS; Maguire AM; Bennett J
    Hum Gene Ther; 2017 Feb; 28(2):154-167. PubMed ID: 27750461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.
    Yau EH; Butler MC; Sullivan JM
    Exp Eye Res; 2016 Oct; 151():236-55. PubMed ID: 27233447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular gene delivery using lentiviral vectors.
    Balaggan KS; Ali RR
    Gene Ther; 2012 Feb; 19(2):145-53. PubMed ID: 22052240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy for inherited retinal degenerations.
    Dalkara D; Sahel JA
    C R Biol; 2014 Mar; 337(3):185-92. PubMed ID: 24702845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques.
    Cho GY; Bolo K; Park KS; Sengillo JD; Tsang SH
    Mol Diagn Ther; 2019 Feb; 23(1):113-120. PubMed ID: 30569401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Survival factors in the treatment of hereditary retinal degeneration].
    Frigg R; Wenzel A; Grimm C; Remé CE
    Ophthalmologe; 2005 Aug; 102(8):757-63. PubMed ID: 15990984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-viral retinal gene therapy: a review.
    Charbel Issa P; MacLaren RE
    Clin Exp Ophthalmol; 2012; 40(1):39-47. PubMed ID: 21745262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Therapy for Inherited Retinal Degeneration.
    Arbabi A; Liu A; Ameri H
    J Ocul Pharmacol Ther; 2019 Mar; 35(2):79-97. PubMed ID: 30688548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease.
    Whiting REH; Jensen CA; Pearce JW; Gillespie LE; Bristow DE; Katz ML
    Exp Eye Res; 2016 May; 146():276-282. PubMed ID: 27039708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.